Risk factors for major bleeding in patients with non-valvular atrial fibrillation and CKD G3-G5D on oral anticoagulants

被引：0
|
作者：
Welander, Frida [1 ]
Renlund, Henrik [2 ]
Sjalander, Anders [3 ]
机构：
[1] Umea Univ, Dept Publ Hlth & Clin Med, Dept Res & Dev Sundsvall, Umea, Sweden
[2] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden
[3] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.066
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
430
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Risk factors for major bleeding in patients with non-valvular atrial fibrillation and CKD G3-G5D on oral anticoagulants
    Welander, Frida
    Renlund, Henrik
    Sjalander, Anders
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I120 - I121
  • [2] Risk factors for major bleeding in patients with atrial fibrillation and CKD G3-G5D on oral anticoagulants
    Welander, Frida
    Renlund, Henrik
    Sjalander, Anders
    CLINICAL KIDNEY JOURNAL, 2024, 17 (08)
  • [3] Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D
    Welander, Frida
    Renlund, Henrik
    Dimeny, Emoeke
    Holmberg, Henrik
    Sjalander, Anders
    CLINICAL KIDNEY JOURNAL, 2023, 16 (05) : 835 - 844
  • [4] Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D
    Welander, Frida
    Renlund, Henrik
    Dimeny, Emoke
    Holmberg, Henrik
    Sjalander, Anders
    CLINICAL KIDNEY JOURNAL, 2022, 15 (06) : 1169 - 1178
  • [5] Warfarin treatment quality and outcomes in patients with non-valvular atrial fibrillation and CKD G3-G5D
    Welander, Frida
    Renlund, Henrik
    Dimeny, Emoke
    Holmberg, Henrik
    Sjalander, Anders
    THROMBOSIS RESEARCH, 2023, 229 : 131 - 138
  • [6] Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D (vol 15, pg 1169, 2022)
    Welander, Frida
    Renlund, Henrik
    Dimeny, Emoke
    Holmberg, Henrik
    Sjalander, Anders
    CLINICAL KIDNEY JOURNAL, 2023, 16 (06) : 1043 - 1043
  • [7] Major Bleeding Risk in Patients With Non-valvular Atrial Fibrillation Concurrently Taking Direct Oral Anticoagulants and Antidepressants
    Chang, Kuo-Hsuan
    Chen, Chiung-Mei
    Wang, Chun-Li
    Tu, Hui-Tzu
    Huang, Yu-Tung
    Wu, Hsiu-Chuan
    Chang, Chien-Hung
    Chang, Shang-Hung
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [8] Naxos study: risk of bleeding with oral anticoagulants in non-valvular atrial fibrillation patients in France
    Danchin, N.
    Steg, P. G.
    Hanon, O.
    Mahe, I
    Falissard, B.
    Belhassen, M.
    Dalon, F.
    Gollety, S.
    Cotte, F. E.
    Van-Ganse, E.
    EUROPEAN HEART JOURNAL, 2020, 41 : 643 - 643
  • [9] Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants
    Beshir, S. A.
    Aziz, Z.
    Yap, L. B.
    Chee, K. H.
    Lo, Y. L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (02) : 209 - 219
  • [10] Impact of Renal Function on Bleeding Risk in Patients With Non-Valvular Atrial Fibrillation Treated With Direct Oral Anticoagulants
    Kobayashi, Tomoaki
    Sotomi, Yohei
    Hirata, Akio
    Hirayama, Atsushi
    Higuchi, Yoshiharu
    CIRCULATION, 2019, 140
12345